Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes

By sjmartinez • November 30, 2024

Rhee CM, Gianchandani RY, Kerr D, Philis-Tsimikas A, Kovesdy CP, Stanton RC, Drincic AT, Galindo RJ, Kalantar-Zadeh K, Neumiller JJ, de Boer IH, Lind M, Kim SH, Ayers AT, Ho CN, Aaron RE, Tian T, Klonoff DC. Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes. J Diabetes Sci Technol. 2024 Nov 29:19322968241292041. doi: 10.1177/19322968241292041. Epub ahead of print. PMID: 39611379; PMCID: PMC11607725.

Tags: Cedars Sinai DoM, Chronic kidney disease, continuous glucose monitor, diabetes, diabetic kidney disease, dialysis, end-stage kidney disease, Endocrinology, Nephrology, Publications, Veterans Administration

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method

Devi J, Samaan S, Sehgal P, Mohamed M, Vincent M, Coombs S, Doering M, Barnes EL, Johnson AM, Yarur AJ, Deepak P. Modulate Obesity and[...]

Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of Hepatic Encephalopathy in Cirrhosis

Singh V, Wang M, Ebinger J, Velazquez A, Cheng S, Kwan AC, Trivedi HD. Glucagon-Like Peptide 1 Receptor Agonists are Associated With Reduced Risk of[...]

Prenatal Substance Exposure and Birth Weight: Findings From the HEALthy Brain and Child Development Study

Bandoli G, Psaras C, Bakhireva LN, Burris HH, Ciciolla L, Coles CD, DeMauro SB, Osmundson SS, Merhar SL, Smith L, Acheson A, Bogdan R, Croff[...]